Evidence map›Paper›PMID 42670857›Full record

ArticleJournal of chemical information and modeling2026

Bend and Snap: Computationally Exploring the Helix Bias for Classifying Abl Kinase Allosteric Modulators.

Pedro Tenório T F Leite, Philipe O Fernandes, Diego M Martins, Rafael Lopes Almeida, Ina Pöhner, Adolfo H Moraes, Thales Kronenberger, Vinícius G Maltarollo

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pedro Tenório T F LeiteDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Minas Gerais 31, Belo Horizonte270-901, Brazil.ORCID 0009-0003-6035-6738
Philipe O FernandesDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Minas Gerais 31, Belo Horizonte270-901, Brazil.ORCID 0000-0001-8089-2958
Diego M MartinsDepartamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais (UFMG), Minas Gerais 31, Belo Horizonte270-901, Brazil.ORCID 0000-0002-6272-5643
Rafael Lopes AlmeidaSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio70211, Finland.ORCID 0000-0002-4003-7030
Ina PöhnerSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio70211, Finland.ORCID 0000-0002-2801-8902
Adolfo H MoraesDepartamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais (UFMG), Minas Gerais 31, Belo Horizonte270-901, Brazil.ORCID 0000-0002-3344-4084
Thales KronenbergerSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio70211, Finland.ORCID 0000-0001-6933-7590
Vinícius G MaltarolloDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Minas Gerais 31, Belo Horizonte270-901, Brazil.ORCID 0000-0001-9675-5907

Funding

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico 304958/2025-5Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior NACSC ? i IT Center for Science NADeutsches Zentrum f?r Infektionsforschung TTU06.716Deutsches Zentrum f?r Infektionsforschung TTU 08.716Financiadora de Estudos e Projetos NAFunda??o de Amparo ? i Pesquisa do Estado de Minas Gerais APQ-004282Funda??o de Amparo ? i Pesquisa do Estado de Minas Gerais RED-00110-23German Federal and State Governments NA
6 · The paper itself

Abstract

Allosteric modulation of Abl kinase via its myristoyl binding pocket is a promising strategy for drug discovery, either aiming at inhibition to treat Chronic Myeloid Leukemia, or activation, under investigation for breast cancer therapy. Although activators and inhibitors can be differentiated by the induced α-helix-I conformation, in silico classification has been proven challenging. Our study distinguishes these classes effectively by integrating multiple computational approaches that account for the conformational plasticity of the regulatory α-helix-I. By evaluating traditional molecular docking, co-folding, and molecular dynamics simulations with methodology benchmarking, we use these methods to uncover mechanistic principles of allosteric modulation. Docking highlighted potentially stabilizing C-F interactions with deep-pocket residues, while co-folding correctly predicted helix bending for inhibitors and outperformed docking in virtual screening. Molecular dynamics revealed that the α-helix-I samples multiple possible conformations and uncovered motions consistent with dynamic coupling between helix bending and long-range restraint of the activation loop, a nuanced mechanism that static models could not elucidate. This study provides a validated framework that combines efficient classification with mechanistic analysis by combining molecular docking, co-folding, and molecular dynamics. Our approach aids in identifying myristoyl pocket ligands, differentiating inhibitors from activators, and suggesting allosteric principles that govern their function, paving the way for more rational design of next-generation, function-specific Abl modulators.

Indexed as

Molecular Docking SimulationMolecular Dynamics SimulationProtein Kinase InhibitorsProto-Oncogene Proteins c-ablAllosteric RegulationHumansProtein Conformation, alpha-HelicalProtein Kinase InhibitorsProto-Oncogene Proteins c-abl

Identifiers

PMID42670857
PMCPMC13509006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.